NCT00469313

Brief Summary

Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative than other traditional indices.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 2, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 4, 2007

Completed
Last Updated

May 22, 2008

Status Verified

May 1, 2008

First QC Date

May 2, 2007

Last Update Submit

May 21, 2008

Conditions

Keywords

copdinspiratory muscle trainingIF

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD GOLD II-III (FEV1\<80 and \>30%)

You may not qualify if:

  • Pregnancy
  • Lung cancer
  • Diabetes mellitus
  • Primary exacerbation of COPD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Hietzing

Vienna, Vienna, 1130, Austria

Location

Related Publications (1)

  • Petrovic M, Reiter M, Zipko H, Pohl W, Wanke T. Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:797-805. doi: 10.2147/COPD.S23784. Epub 2012 Nov 30.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Reiter

    Hospital Hietzing, A 1130, Vienna, Austria

    STUDY CHAIR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 2, 2007

First Posted

May 4, 2007

Study Start

May 1, 2007

Last Updated

May 22, 2008

Record last verified: 2008-05

Locations